Notably, one BRCA1/2 wild-type TNBC tumor that had low Trop-2 expression and was proficient in HRR [23], namely MDA-MB-231 (~30,000 surface Trop-2 molecules per cell), was not responsive to this combination. This evidence concerns the gene TACSTD2 and neoplasm.